Sign in
4/A

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-22-000050

Chief Executive Officer sold 9,718 shares at $2.03 ($19,706)

From the SEC's structured data for this filing

Trades in this filing

Hively Brad · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-15 Sale : show line 1 in the form −9,718 $2.03 $19,706 452,201 D
Open-market sales · 9,718 sh · avg $2.03 · $19,706
Loading xslF345X03/edgardoc.xml…